Drugs / [11C]-carfentanil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05547542 Background | Mar 2023 → Jul 2024 | substance-related disorder | Cerevel Therapeutics, LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]-carfentanil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05547542 ↗ |